Energy News
CIVIL NUCLEAR
Cernavoda set to become hub for Lutetium-177 production in Europe
Lutetium-177 is a beta-emitting radioisotope used in targeted radionuclide therapy for the treatment of prostate cancer and in multiple promising radiopharmaceutical developments for other cancer indications. The isotope destroys cancer cells while leaving healthy cells unaffected. Framatome's proprietary isotope production technology enabled the first large-scale commercial production of Lutetium-177 in a power reactor in June 2022.
Cernavoda set to become hub for Lutetium-177 production in Europe
by Sophie Jenkins
London, UK (SPX) Dec 01, 2023

Framatome and SN Nuclearelectrica SA, the leading nuclear energy provider in Romania, have forged a significant partnership to potentially produce the medical isotope Lutetium-177 at the Cernavoda nuclear power plant. This cooperation, announced during the World Nuclear Exhibition 2023, aims to leverage nuclear technology for critical healthcare applications, particularly in cancer treatment.

The collaboration's initial phase involves a technical feasibility study, relying on Framatome's successful isotopes production technology, previously implemented in Canada. The focus is on maximizing Cernavoda's existing infrastructure to produce medical isotopes, alongside its primary function of generating reliable, low-carbon electricity.

Lutetium-177, the focal point of this agreement, is a beta-emitting radioisotope increasingly used in targeted radionuclide therapy. It has shown promising results in the treatment of prostate cancer and is being explored for other cancer indications. Its ability to selectively destroy cancer cells while minimizing damage to healthy tissue makes it a valuable asset in the fight against cancer.

Francois Gauche, Director of Framatome Healthcare, expressed enthusiasm about the project. He stated, "Mass access to nuclear medicine is closely linked to the development of large-scale, reliable, and diversified supply chains, and we want to play our part in the fight against cancer by helping build these supply chains." Gauche also emphasized the need for regional nuclear medicine production hubs, viewing this project as a crucial step in strengthening the supply chain in Europe.

Cosmin Ghita, CEO of Nuclearelectrica, highlighted the broader benefits of the partnership. "This partnership is a significant step to help improve the health of millions of people and demonstrate the multiple benefits of nuclear power plants, which generate clean energy, contribute to energy stability, decarbonization, and economic growth," he declared.

Teodor Chirica, President of the Board at Nuclearelectrica SA, also shared his excitement about collaborating with Framatome, noting the potential to showcase the benefits of nuclear energy beyond clean energy production.

Framatome's proprietary isotope production technology enabled the first large-scale commercial production of Lutetium-177 in a power reactor in June 2022, demonstrating the company's leadership in this field. The Cernavoda nuclear power plant, with its 27 years of operational experience and involvement in strategic projects, is well-positioned to support this innovative endeavor.

Framatome Healthcare, dedicated to advancing healthcare solutions, plays a crucial role in this initiative. The division focuses on developing products and services for the healthcare industry, including supporting the radioisotopes value chain used in radiopharmaceuticals for both diagnostic imaging and therapeutic purposes.

Related Links
Framatome
Nuclear Power News - Nuclear Science, Nuclear Technology
Powering The World in the 21st Century at Energy-Daily.com

Subscribe Free To Our Daily Newsletters
Tweet

RELATED CONTENT
The following news reports may link to other Space Media Network websites.
CIVIL NUCLEAR
Framatome signs a services contract with EDF for Flamanville 3 Instrumentation and Control
Paris, France (SPX) Dec 01, 2023
Framatome has solidified its role in France's nuclear energy sector by signing a five-year services contract for the digital Instrumentation and Control (I&C) system of the Flamanville 3 EPR reactor, owned by EDF (Electricite de France). This agreement, finalized during the World Nuclear Exhibition 2023, is centered on in-service support for the I&C protection system of this pivotal nuclear project. The protection system at Flamanville 3 utilizes Framatome's TELEPERM XS platform, a technology spec ... read more

CIVIL NUCLEAR
Nigerians look to biofuel as cost of cooking gas soars

Chinese company gives leftover hotpot oil second life as jet fuel

Cheap and efficient ethanol catalyst from laser-melted nanoparticles

UK permits 'world-first' flight powered by sustainable fuels

CIVIL NUCLEAR
Solar-Powered Economic Growth: Qihe County's Commitment to Sustainable Energy

Nations rally behind renewables at COP28 climate talks

Tripling renewable energy by 2030 'ambitious but doable'

Innovative supercrystal material ushers new era in solar energy efficiency

CIVIL NUCLEAR
UK unveils massive news windfarm investment by UAE, German firms

Wind and solar projects can profit from bitcoin mining

Winds of change? Bid to revive England's onshore sector

Drones to transport personnel and materials to offshore wind farms

CIVIL NUCLEAR
COP28: Why energy efficiency matters so much

World Bank to operate 'loss and damage' climate fund

US pledges $3 billion to green climate fund at COP28

Banks could face rules on climate risk reporting

CIVIL NUCLEAR
Japanese experimental nuclear fusion reactor inaugurated

Cost-effective electrocatalysts for cleaner hydrogen fuel production

New study shows how universities are critical to emerging fusion industry

Glencore eyes options on battery recycling project

CIVIL NUCLEAR
Fast-fashion giant Shein applies to go public in US: report

Top Panama court strikes down contested mining contract

Record COP28 carbon footprint under scrutiny

Virtual floats reduce waste at Thai festival

CIVIL NUCLEAR
Nations urged to phase out fossil fuels at UN climate talks

COP28 puts spotlight on state oil giants

COP28 president denies using climate talks to push oil deals

Lula says Brazil will join OPEC+ but push cutting fossil fuels

CIVIL NUCLEAR
Perseverance's Parking Spot

NASA uses two worlds to test future Mars helicopter designs

California lawmakers ask NASA not to cut Mars budget

Spacecraft fall silent as Mars disappears behind the Sun

Subscribe Free To Our Daily Newsletters




The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us.